CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Natalia Szejko

OPENALEX: A5071202638↗ORCID: 0000-0001-6160-9221↗

Affiliations

Organizations

Medical University of Warsawauthorship · PL Medizinische Hochschule Hannoverauthorship · DE University of Calgaryauthorship · CA Yale Universityauthorship · US

Public evidence

4 connected articles

Case Report: Effect of medicinal cannabis on fitness to drive in a patient with Tourette Syndrome and ADHD.2025 · Europe PMC Long-term use of cannabis-based medicines in two children with Tourette syndrome: a case report.2025 · Europe PMC European clinical guidelines for Tourette syndrome and other tic disorders-version 2.0. Part III: pharmacological treatment.2021 · PubMed Central Open Access Association of a Variant of <i>CNR1</i> Gene Encoding Cannabinoid Receptor 1 With Gilles de la Tourette Syndrome.2020 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.

Natalia Szejko - Medical Cannabis Research Engine